Skip to content

Clinical trials

Phase 3 Cellulitis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cellulitis Phase: Phase 3 Country / region: United States Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20075
20082
20092
20102
20112
20121
20131
20141
20151
20182

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Durata Therapeutics Inc., an affiliate of Allergan plc3
Melinta Therapeutics, Inc.3
Arpida AG2
Forest Laboratories2
Verrica Pharmaceuticals Inc.2
59th Medical Wing1
Arrevus Inc.1
GlaxoSmithKline1
Paratek Pharmaceuticals Inc1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cellulitis21
Abscess10
Wound Infection6
Bacterial Infections5
Surgical Wound Infection5
Skin Diseases, Bacterial4
Infections3
Staphylococcal Infections3
Molluscum Contagiosum2
Poxviridae Infections2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.